As yet, Glaxo has no way to predict who is at risk and ensure that they are informed of the dangers. Abacavir's Price On December 1, World AIDS Day, Glaxo took the unusual step of announcing abacavir's price before FDA approval had become official. Community members attending a November 4 meeting with Glaxo officials report that the company was impressed by the efavirenz dispute and wished to avoid the same sort of public debacle. Reproduced with permission. Inc. All rights reserved.
Noncommercial reproduction is encouraged.
Subscription lists are kept confidential. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only.